These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35430137)

  • 1. Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center.
    González-Padilla DA; Subiela JD; González-Díaz A; Hernández-Arroyo M; García-Rojo E; Aumatell J; Burgos Revilla J; Rodríguez-Antolín A; Guerrero-Ramos F
    Urol Oncol; 2022 Jul; 40(7):345.e19-345.e23. PubMed ID: 35430137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
    Tan WS; Prendergast A; Ackerman C; Yogeswaran Y; Cresswell J; Mariappan P; Phull J; Hunter-Campbell P; Lazarowicz H; Mishra V; Rane A; Davies M; Warburton H; Cooke P; Mostafid H; Wilby D; Mills R; Issa R; Kelly JD
    Eur Urol; 2023 Jun; 83(6):497-504. PubMed ID: 35999119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
    Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.
    van Valenberg FJP; van der Heijden AG; Lammers RJM; Falke J; Arends TJH; Oosterwijk E; Witjes JA
    Int J Hyperthermia; 2018 Nov; 34(7):988-993. PubMed ID: 29191126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
    González-Padilla DA; González-Díaz A; Guerrero-Ramos F; Rodríguez-Serrano A; García-Jarabo E; Corona-laPuerta M; Rodríguez-Antolín A; Villacampa-Aubá F
    Urol Oncol; 2021 Jan; 39(1):76.e9-76.e14. PubMed ID: 32753359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.
    Grimberg DC; Dudinec J; Shah A; Inman BA
    Urol Oncol; 2021 Aug; 39(8):498.e13-498.e20. PubMed ID: 33485761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.
    Sousa A; Piñeiro I; Rodríguez S; Aparici V; Monserrat V; Neira P; Carro E; Murias C; Uribarri C
    Int J Hyperthermia; 2016 Jun; 32(4):374-80. PubMed ID: 26915466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
    León-Mata J; Domínguez JL; Redorta JP; Sousa González D; Alvarez Casal M; Sousa Escandón A; Piñeiro Vázquez E
    Arch Esp Urol; 2018 May; 71(4):426-437. PubMed ID: 29745932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.
    Angulo JC; Álvarez-Ossorio JL; Domínguez-Escrig JL; Moyano JL; Sousa A; Fernández JM; Gómez-Veiga F; Unda M; Carballido J; Carrero V; Fernandez-Aparicio T; García de Jalón Á; Solsona E; Inman B; Palou J
    Eur Urol Oncol; 2023 Feb; 6(1):58-66. PubMed ID: 36435738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].
    Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich MG
    Urologe A; 2008 May; 47(5):608-15. PubMed ID: 18317718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.
    Tan WP; Chang A; Brousell SC; Grimberg DC; Fantony JJ; Longo TA; Etienne W; Spasojevic I; Maccarini P; Inman BA
    Int J Hyperthermia; 2020; 37(1):854-860. PubMed ID: 32664768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
    Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C for the treatment of bladder cancer.
    Volpe A; Racioppi M; D'Agostino D; Cappa E; Filianoti A; Bassi PF
    Minerva Urol Nefrol; 2010 Jun; 62(2):133-44. PubMed ID: 20562793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer.
    Wen YC; Lee LM; Lin YW; Syu SH; Lin KH; Fan YC; Lee HL; Lai BCH; Shih HJ
    Int J Hyperthermia; 2021; 38(1):1627-1632. PubMed ID: 34775895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
    Bahouth Z; Halachmi S; Moskovitz B; Nativ O
    Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    van Valenberg H; Colombo R; Witjes F
    Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients.
    Milla P; Fiorito C; Soria F; Arpicco S; Cattel L; Gontero P
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):503-9. PubMed ID: 24442034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.
    Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi P
    Eur Urol Oncol; 2019 Sep; 2(5):576-583. PubMed ID: 31411974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Irani J
    Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.